![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.630, 2011-01, pp. : 14-14
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
NICE issues draft guidance on abiraterone for prostate cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 647, 2012-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Latest NICE draft guidance is good news for ivabradine . . .
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 660, 2012-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
NICE issues guidance on alteplase for stroke . . .
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 664, 2012-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
NICE issues guidance on fludarabine, taxanes
Inpharma, Vol. 1, Iss. 1310, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
NICE issues guidance on fludarabine, taxanes
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 335, 2001-01 ,pp. :